First do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents.
OBJECTIVE
To review the evidence for efficacy and metabolic effects of atypical antipsychotics (AAPs), and to propose a metabolic monitoring protocol for AAP use in children and adolescents.


METHODS
A PubMed search was performed to obtain all studies related to efficacy, metabolic side-effects, and monitoring in those less than 18 years of age.


RESULTS
There are no approved indications for AAP use in children and adolescents in Canada. Based on US Food and Drug Administration approvals and a review of randomized controlled trials, we identified 7 indications for AAP use that target specific symptoms in youth including schizophrenia, bipolar I disorder, autism, pervasive developmental disorder, disruptive behaviour disorders (including conduct disorder and ADHD), developmental disabilities and Tourette Syndrome. A wide range of metabolic effects including weight gain, increased waist circumference, dysglycemia, dyslipidemia, hypertension, elevated hepatic transaminases and prolactin levels have been reported. We have developed a proposal for metabolic monitoring that includes anthropometric measurements and laboratory testing at baseline and appropriate intervals thereafter.


CONCLUSIONS
There is an urgent need for national clinical practice guidelines that provide, not only appropriate treatment algorithms for AAP-use based on evidence, but also address metabolic monitoring and subsequent management of complications in this vulnerable population.
Panagiotopoulos
Constadina
C
Department of Pediatrics, University of British Columbia, Vancouver, British Columbia. dpanagiotopoulos@cw.bc.ca
Ronsley
Rebecca
R
Elbe
Dean
D
Davidson
Jana
J
Smith
Derryck H
DH
J Clin Psychiatry. 2009 Apr 21;70(5):756-64
19389329
Am J Psychiatry. 2008 Nov;165(11):1420-31
18794207
J Child Adolesc Psychopharmacol. 2007 Apr;17(2):217-22
17489716
Schizophr Res. 2004 Sep 1;70(1):1-17
15246458
J Child Adolesc Psychopharmacol. 2006 Oct;16(5):541-8
17069543
Am J Psychiatry. 2004 Mar;161(3):414-25
14992963
Schizophr Bull. 2010 Mar;36(2):410-8
18703666
J Am Acad Child Adolesc Psychiatry. 2002 Sep;41(9):1026-36
12218423
Psychiatr Serv. 2002 Apr;53(4):425-30
11919355
Can J Psychiatry. 2007 Jun;52(6):363-8
17696022
J Am Acad Child Adolesc Psychiatry. 2004 Feb;43(2):206-14
14726728
J Am Acad Child Adolesc Psychiatry. 2002 Mar;41(3):337-43
11886029
J Clin Psychiatry. 2004 Jun;65(6):857-63
15291665
J Am Acad Child Adolesc Psychiatry. 2003 Oct;42(10):1227-33
14560173
Eur Neuropsychopharmacol. 2001 Oct;11 Suppl 4:S397-403
11587887
Neurology. 2003 Apr 8;60(7):1130-5
12682319
J Clin Psychiatry. 2001 Jan;62(1):50-6
11235929
Am J Psychiatry. 2004 Jun;161(6):1125-7
15169706
J Clin Psychopharmacol. 2004 Oct;24(5 Suppl 1):S7-14
15356415
Aust N Z J Psychiatry. 2003 Feb;37(1):55-61
12534657
J Child Adolesc Psychopharmacol. 2008 Jun;18(3):227-36
18582177
Am J Gastroenterol. 2000 Jan;95(1):272-6
10638596
Am J Psychiatry. 2007 Oct;164(10):1547-56
17898346
J Child Adolesc Psychopharmacol. 2002 Summer;12(2):83-91
12188977
N Engl J Med. 2002 Aug 1;347(5):314-21
12151468
J Clin Psychiatry. 2001 Apr;62(4):239-48
11379837
Am J Psychiatry. 2005 Jun;162(6):1142-8
15930063
Res Dev Disabil. 2009 Mar-Apr;30(2):386-96
18768293
Int J Pediatr Obes. 2009;4(4):325-31
19922048
J Clin Psychiatry. 2009 Oct;70(10):1441-51
19906348
Pharmacotherapy. 2004 Jul;24(7):824-30
15303445
Pediatrics. 2009 Dec;124(6):1533-40
19948625
Arch Gen Psychiatry. 2006 Jun;63(6):679-85
16754841
J Am Acad Child Adolesc Psychiatry. 2002 Mar;41(3):330-6
11886028
J Child Adolesc Psychopharmacol. 2009 Apr;19(2):101-9
19364288
JAMA. 2009 Oct 28;302(16):1765-73
19861668
Curr Psychiatry Rep. 2009 Apr;11(2):156-61
19302770
J Child Adolesc Psychopharmacol. 1999;9(4):239-45
10630453
Am J Psychiatry. 2008 Nov;165(11):1432-41
18765484
Diabetes Care. 2004 Feb;27(2):596-601
14747245
JAMA. 2003 Nov 5;290(17):2271-6
14600185
J Am Acad Child Adolesc Psychiatry. 2006 Jul;45(7):771-91
16832314
J Am Acad Child Adolesc Psychiatry. 2006 Mar;45(3):305-313
16540815
Diabetes Care. 2009 Jun;32(6):1037-42
19244091
N Engl J Med. 2004 Jun 3;350(23):2362-74
15175438
N Engl J Med. 1998 Jun 4;338(23):1650-6
9614255
Pediatrics. 2004 Feb;113(2):421-2; author reply 421-2
14754964
J Am Acad Child Adolesc Psychiatry. 2009 Jan;48(1):60-70
19057413
Harv Rev Psychiatry. 2006 May-Jun;14(3):152-64
16787887
J Child Adolesc Psychopharmacol. 2009 Oct;19(5):563-73
19877981
Clin Ther. 2006 May;28(5):794-800
16861101
Int Rev Psychiatry. 2005 Jun;17(3):173-80
16194788
J Am Acad Child Adolesc Psychiatry. 2007 Oct;46(10):1349-1356
17885577
J Clin Psychopharmacol. 2008 Oct;28(5):494-9
18794643
CNS Drugs. 2005;19 Suppl 1:1-93
15998156
Biol Psychiatry. 2007 Feb 15;61(4):545-50
16730335
Ambul Pediatr. 2006 Mar-Apr;6(2):79-83
16530143
Psychiatr Serv. 2008 May;59(5):507-14
18451006
J Clin Psychiatry. 2008 Jul;69(7):1166-75
18588363
Ann Pharmacother. 2000 Apr;34(4):483-6
10772436
J Clin Psychiatry. 2005 Jan;66(1):80-4
15669892
J Child Adolesc Psychopharmacol. 2000 Winter;10(4):259-68
11191686
J Child Neurol. 2006 Jun;21(6):450-5
16948927
Eur Child Adolesc Psychiatry. 2008 Feb;17(1):1-8
18080171
Pediatrics. 2004 Nov;114(5):e634-41
15492353
Pharmacopsychiatry. 2004 Jan;37(1):1-11
14750042
Eur Child Adolesc Psychiatry. 2002 Jun;11(3):129-33
12369772
Am J Psychiatry. 2002 Aug;159(8):1337-46
12153826
Drug Saf. 2007;30(7):569-79
17604408
J Child Adolesc Psychopharmacol. 2005 Dec;15(6):869-84
16379507
Am J Psychiatry. 2004 Apr;161(4):677-84
15056514
Eur Child Adolesc Psychiatry. 2009 Jul;18(7):418-28
19198920
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):849-57
18258348
JAMA. 2001 Nov 28;286(20):2547-8
11722267
J Am Acad Child Adolesc Psychiatry. 2007 May;46(5):558-565
17450046
Drugs. 2004;64(7):701-23
15025545
Pediatrics. 2002 Sep;110(3):e34
12205284
Am J Ment Retard. 2001 Nov;106(6):525-38
11708938
J Clin Psychiatry. 2006 Jul;67(7):1110-3
16889455
J Child Adolesc Psychopharmacol. 2001 Winter;11(4):389-94
11838821
J Clin Psychopharmacol. 2004 Jun;24(3):343-5
15118491
Psychoneuroendocrinology. 2003 Jan;28 Suppl 1:1-7
12504068
J Child Adolesc Psychopharmacol. 2004 Summer;14(2):243-54
15319021
Br J Psychiatry. 2009 Feb;194(2):158-64
19182179
J Am Acad Child Adolesc Psychiatry. 2009 Nov;48(11):1110-1119
19797985
J Neural Transm (Vienna). 2007 Feb;114(2):273-80
17109073
J Child Adolesc Psychopharmacol. 2007 Aug;17(4):487-502
17822343
J Autism Dev Disord. 2007 Feb;37(2):367-73
17019624
Psychopharmacology (Berl). 2006 Jul;186(4):572-8
16601995
J Child Adolesc Psychopharmacol. 2007 Jun;17(3):303-11
17630864
J Child Adolesc Psychopharmacol. 1999;9(2):93-8
10461819
Evid Based Ment Health. 2009 Aug;12(3):93
19633261
J Am Acad Child Adolesc Psychiatry. 2002 Dec;41(12):1439-46
12447030
CNS Drugs. 2002;16(2):77-89
11825099
JAMA. 2003 Nov 5;290(17):2277-83
14600186
J Am Acad Child Adolesc Psychiatry. 2002 Oct;41(10):1216-23
12364843
J Child Adolesc Psychopharmacol. 2009 Oct;19(5):575-82
19877982
J Am Acad Child Adolesc Psychiatry. 1997 May;36(5):701-5
9136506
Can J Psychiatry. 2009 Nov;54(11):743-9
19961662
Dig Dis Sci. 2000 Jan;45(1):210-4
10695637
J Am Acad Child Adolesc Psychiatry. 2000 Mar;39(3):292-9
10714048
Arch Pediatr Adolesc Med. 2008 Oct;162(10):929-35
18838645
Australas Psychiatry. 2008 Aug;16(4):253-62
18608172
Pediatr Diabetes. 2007 Oct;8(5):299-306
17850473
Ann Intern Med. 1998 Jul 1;129(1):36-8
9652997
J Child Adolesc Psychopharmacol. 2008 Feb;18(1):54-69
18294089
Bipolar Disord. 2009 Aug;11(5):483-93
19624387
Am J Psychiatry. 2009 Mar;166(3):345-53
19147694
Am J Psychiatry. 2006 Mar;163(3):402-10
16513860
J Clin Psychiatry. 2003 Nov;64(11):1362-9
14658952
J Child Adolesc Psychopharmacol. 2008 Apr;18(2):140-56
18439112
J Am Acad Child Adolesc Psychiatry. 2005 Aug;44(8):748-55
16034276